PFS Genomics

Michigan, United States Founded: 2015 • Age: 11 yrs Acquired By Exact Sciences
Provider of cancer detection treatment guidance services

About PFS Genomics

PFS Genomics is a Healthcare company based in United States founded in 2015 by Corey W Speers, Felix Y Feng, and Lori J Pierce, and was acquired by Exact Sciences in May 2021. Provider of cancer detection treatment guidance services. PFS Genomics offers products and services including Cologuard® test, Oncotype DX Breast Recurrence Score® test, Oncotype DX Colon Recurrence Score® test, and OncoExTra® test. Its focus areas include Services for Healthcare Providers and Medical Information Providers. Its legal entity is Exact Sciences Corporation.

Company details

PFS Genomics was established in 2015 in Michigan, United States, by co-founders Corey W Speers, Felix Y Feng, and Lori J Pierce. Genomic-based services for cancer detection and treatment guidance are delivered to support oncology practices. Operations are centered in the healthcare sector, with a focus on precision medicine applications. The companys domain, pfsgenomics.com, facilitates access to these specialized resources for medical professionals and patients.

  • Headquarters Michigan, United States
  • Founders Corey W Speers, Felix Y Feng, Lori J Pierce
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website pfsgenomics.com
  • Social LinkedIn
  • Acquired by Exact Sciences (May 2021)
  • Legal Name Exact Sciences Corporation
Key Metrics

Products & Services of PFS Genomics

PFS Genomics offers a comprehensive portfolio of products and services, including Cologuard® test, Oncotype DX Breast Recurrence Score® test, Oncotype DX Colon Recurrence Score® test, and OncoExTra® test.

Cologuard® test
Cancer Screening

Test for early detection of colorectal cancer using stool DNA analysis.

Oncotype DX Breast Recurrence Score® test
Breast Cancer Diagnostics

Genomic assay to predict breast cancer recurrence risk.

Oncotype DX Colon Recurrence Score® test
Colon Cancer Diagnostics

Test to assess colon cancer recurrence and guide treatment.

OncoExTra® test
Advanced Diagnostics

Comprehensive genomic profiling for various cancers.

Investors in PFS Genomics

PFS Genomics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Exact Sciences.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Non-invasive molecular diagnostic tests for cancer detection are provided.
1995exactsciences.comMadison, United States
Premium access

Investor details for PFS Genomics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of PFS Genomics

3 people are tracked at PFS Genomics (3 in leadership).

NameRoleGroup
Corey W Speers
Co-FounderLeadership
Felix Y Feng
Co-FounderLeadership
Lori J Pierce
Co-FounderLeadership
Premium access

Complete people profiles for PFS Genomics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of PFS Genomics

2 dated milestones of PFS Genomics across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded PFS Genomics is founded.
  2. Exit Acquired by Exact Sciences.

Top companies in Healthcare Provider Support Services

3 companies that operate in the same segment as PFS Genomics (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of self funded health plan
2017New York, New York, United StatesUSD 224 M212
Provider of AI solutions for clinical, operational, and business outcomes
2005Princeton, New Jersey, United StatesUSD 1.13 BUSD 465.22 M5,442
AMN Healthcare is recognized as a leading healthcare staffing provider.
1985San Diego, California, United StatesUSD 2.73 B2,970
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pfs Genomics

Premium access

Complete news archive for PFS Genomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PFS Genomics

PFS Genomics was founded in 2015.

PFS Genomics is headquartered in United States. It is registered at Michigan, United States.

PFS Genomics was established in 2015 in Michigan, United States, by co-founders Corey W Speers, Felix Y Feng, and Lori J Pierce. Genomic-based services for cancer detection and treatment guidance are delivered to support oncology practices. Operations are centered in the healthcare sector, with a focus on precision medicine applications. The companys domain, pfsgenomics.com, facilitates access to these specialized resources for medical professionals and patients.

PFS Genomics offers Cologuard® test, Oncotype DX Breast Recurrence Score® test, Oncotype DX Colon Recurrence Score® test, and OncoExTra® test.

PFS Genomics has 1 investor. Key investors include Exact Sciences.

PFS Genomics operates through Exact Sciences Corporation.

Yes. PFS Genomics was acquired by Exact Sciences in May 2021.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available